It Is the Time to Think About a Treat-to-Target Strategy for Knee Oste | TCRM
It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
d the most relevant publications are limited to isolated case reports. This systematic review aimed to identify the clinical features and other potential markers (autoantibodies)…
gitudinal RP medication use, from data collected by semiannual questionnaires. We evaluated factors associated with RP medication use with multivariable Andersen and Gill Cox proportional…
the contrast in their approach to treat different PsA domains. Methods Major global guidelines for PsA management were reviewed, including American College of Rheumatology 2018…
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters…
osuppressive (CI) therapy with rituximab (RTX) and MMF, along with the antifibrotic nintedanib, have also become options. We aimed to better understand prescribing patterns and…
e, and Cochrane databases. A meta-analysis was conducted to evaluate the relationship between MTX response and the MTRR 66 A/G and MTR 2756 A/G polymorphisms.…
o evaluate the impact of persistent disease activity and moderate-severe damage on mortality. Methods Adult SSc patients with a disease duration ≤7 years were enrolled…
Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists [Podcast]
gitudinal RP medication use, from data collected by semiannual questionnaires. We evaluated factors associated with RP medication use with multivariable Andersen and Gill Cox proportional…